STOCK TITAN

IT Tech Packaging, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Negative)
Tags
Rhea-AI Summary

IT Tech Packaging, Inc. (ITP) reported its Q4 and FY2020 financial results, highlighting a 3.4% decrease in revenues to $32.48 million from $33.61 million year-over-year. Gross profit plummeted 86.7% to $0.75 million, with a gross margin of 2.3%. The company faced a net loss of $2.69 million or $0.06 per share, compared to a profit of $2.16 million in Q4 2019. For the full year, revenues dropped 14.2% to $100.94 million, with a comprehensive loss of $5.55 million. Despite growth in tissue paper sales, the declines in other segments fueled overall losses.

Positive
  • Tissue paper product sales increased by 51.3% to $2.65 million in Q4 2020.
  • Face mask revenue reached $1.1 million for the full year 2020.
Negative
  • Total revenues declined by 14.2% for FY2020, primarily due to decreased sales volumes.
  • Net loss increased by 350% to $5.55 million for FY2020.

BAODING, China, March 23, 2021 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced its unaudited financial results for the fourth quarter and audited financial results for the fiscal year ended December 31, 2020.

Fourth Quarter 2020 Financial Results



 For the Three Months Ended December 31,

 ($ millions)


2020


2019


 % Change

 Revenues


32.48


33.61


-3.4%

 Regular Corrugating Medium Paper ("CMP")*


19.68


19.61


0.3%

 Light-Weight CMP**


5.24


5.08


3.1%

 Offset Printing Paper


4.88


7.16


-31.9%

 Tissue Paper Products


2.65


1.75


51.3%

  Face Masks


0.04


NM


NM








 Gross profit


0.75


5.60


-86.7%

 Gross profit (loss) margin


2.3%


16.7%


-14.4 pp****

 Regular Corrugating Medium Paper ("CMP")*


1.4%


15.4%


-14.0 pp****

 Light-Weight CMP**


3.9%


18.3%


-14.4 pp****

 Offset Printing Paper


13.6%


33.7%


-20.1pp****

 Tissue Paper Products***


-15.0%


-43.1%


28.1 pp****

 Face Masks


5.81%


NM


NM








 Operating income (loss)


-1.97


3.19


-161.7%

 Net income


-2.69


2.16


-224.8%

 EBITDA


1.56


6.98


-77.6%

 Basic and Diluted earnings (loss) per share


-0.06


0.10


-160.0%








 * Products from PM6







 ** Products from PM1







 *** Products from PM8 and PM9







 **** pp represents percentage points







 

  • Revenue slightly decreased by 3.4% to $32.48 million, primarily attributable to a decrease in sales volume of offset printing paper.
  • Gross profit decreased by 86.7% to $0.75 million. Total gross margin decreased by 14.4 percentage point to 2.3%.  
  • Loss from operations was $1.97 million, compared to income from operations of $3.19 million for the same period of last year.
  • Net loss was $2.69 million, or loss of $0.06 per basic and diluted share, compared to net income of $2.16 million, or $0.10 per basic and diluted share, for the same period of last year.
  • Earnings before interest, taxes, depreciation and amortization ("EBITDA") decreased by 77.6% to $1.56 million.

Mr. Zhenyong Liu, Chairman and Chief Executive Officer of the Company, commented, "We continued to making improvements in the sales volume of tissue paper products and posted slight decrease in sales of CMP products for this quarter. Our total revenue had a slight decline of 3.4% to $32.5 million but we managed to grow sales from tissue paper products by 51.3% to a total volume of 3,165 tonnes for this quarter. The average selling prices (ASPs) of our products for this quarter increased by 5.6% from Q3 2020, or a minor growth compared to the same period last year (Q4 2019).

"We took a quick recovery from the impact caused by global outbreaks of COVID-19 pandemic, posting growing revenues from sales of tissue paper, regular and light-weight CMP products. Our production and sales of tissue paper products have been growing up steadily since the launch of PM8 and PM9 in December 2018 and November 2019.

"Currently we are in the process to apply for surgical face masks production license which we expect to boost both our sales and margins in the very near future. Though on-site inspection on our production facilities by the authorities was delayed by the pandemic, we are expecting final review results by local food and drug administration in Hebei province. We anticipate to obtain the license once the relevant review works are finished."

Revenue

For the fourth quarter of 2020, total revenue decreased by $1.1 million, or 3.4%, to $32.5 million from $33.6 million for the same period of last year. The decrease in total revenue was mainly due to the decrease in sales volume of CMP and offset printing paper.

The following table summarizes revenue, volume and ASP by product for the fourth quarter of 2020 and 2019, respectively:


 For the Three Months Ended December 31,


2020


2019


 Revenue ($'000)


 Volume (tonne)


 ASP ($/tonne)


 Revenue ($'000)


 Volume (tonne)


 ASP ($/tonne)

 Regular CMP

19,677


45,210


435


19,610


47,063


417

 Light-Weight CMP

5,242


12,417


422


5,083


12,582


404

 Offset Printing Paper

4,877


7,895


618


7,162


10,450


685

 Tissue Paper Products

2,648


3,164


837


1,751


2,558


684

 Total

32,444


68,686


472


33,606


72,654


463














 Revenue ($'000)


 Volume (thousand pieces)


 ASP ($/thousand pieces)


 Revenue ($'000)


 Volume ($/thousand pieces)


 ASP ($/thousand pieces)

 Face Masks

35


445


79


 NM


 NM


 NM

 

Revenue from CMP, including both regular CMP and light-Weight CMP, increased by $0.2 million, or 0.9%, to $24.9 million and accounted for 76.7% of total revenue for the fourth quarter of 2020, compared to $24.7 million, or 73.5% of total revenue, for the same period of last year. The Company sold 57,627 tonnes of CMP at an ASP of $432/tonne in the fourth quarter of 2020, compared to 59,646 tonnes at an ASP of $414/tonne in the same period of last year.

Of the total CMP sales, revenue from regular CMP increased by $0.1 million, or 0.3%, to $19.7 million, resulting from sales of 45,210 tonnes at an ASP of $435/tonne, during the fourth quarter of 2020, compared to revenue of $19.6 million, resulting from sales of 47,063 tonnes at an ASP of $417/tonne, for the same period of last year. Revenue from light-weight CMP increased by $0.2 million, or 3.1%, to $5.2 million, resulting from sales of 12,417 tonnes at an ASP of $422/tonne for the fourth quarter of 2020, compared to revenue of $5.1 million, resulting from sales of 12,583 tonnes at an ASP of $404/tonne for the same period of last year.

Revenue from offset printing paper decreased by $2.3 million, or 31.9%, to $4.9 million for the fourth quarter of 2020, from $7.2 million for the same period of last year. The Company sold 7,895 tonnes of offset printing paper at an ASP of $618/tonne in the fourth quarter of 2020, compared to 10,450 tonnes at an ASP of $685/tonne in the same period of last year.

Revenue from tissue paper products increased by $0.9 million, or 51.3%, to $2.6 million, resulting from sales of 3,165 tonnes at an ASP of $837/tonne, for the fourth quarter of 2020, compared to revenue of $1.7 million, resulting from sales of 2,558tonnes at an ASP of $684/tonne for the same period of last year.

Revenue generated from selling face masks was $0.04 million for the fourth quarter ended December 31, 2020. The Company sold 445 thousand pieces of face masks in the fourth quarter of 2020.

Gross Profit and Gross Margin

Total cost of sales increased by $3.7 million, or 13.2%, to $31.7 million for the fourth quarter of 2020 from $28.0 million for the same period of last year. For paper products, overall cost of sales per tonne was $462 for the fourth quarter of 2020, compared to $388 for the same period of last year. The increase in overall cost of sales was mainly due to the increased manufacturing overhead costs and increased material costs, specifically higher average unit purchase costs of recycled paper board and recycled white scrap paper in the fourth quarter of 2020.  Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper, and tissue paper products were $429, $406, $534, and $962, respectively, for the fourth quarter of 2020, compared to $353, $330, $454 and $979, respectively, for the same period of last year. Total gross profit was $0.7 million for the fourth quarter of 2020, compare to the gross profit of $5.6 million for the same period of last year as a result of factors described above. Overall gross margin was 2.3% for the fourth quarter of 2020, compared to 16.7% for the same period of last year. Gross profit (loss) margins for regular CMP, light-weight CMP, offset printing paper, tissue paper products and face mask products were 1.4%, 3.9%, 13.6%, -15.0% and 5.81%, respectively, for the fourth quarter of 2020, compared to 15.4%, 18.3%, 33.7%,-45.1%,-43.1 and nil, respectively, for the same period of last year.

Selling, General and Administrative Expenses

Selling, general and administrative expenses ("SG&A") increased by $0.3 million, or 14.6%, to $2.7 million for the fourth quarter of 2020 from $2.4 million for the same period of last year. The increase was mainly due to issuance of 2,000,000 shares of common stock valued at $1,200,000 to officers and directors under the Company's omnibus equity incentive plan. 

Income (loss) from Operations

Loss from operations was $2.0 million for the fourth quarter of 2020, compared to income from operations of $3.2 million for the same period of last year. The decrease in income from operations was primarily due to increased SG&A expenses and decreased gross profit this quarter as discussed above. Operating margin was -6.1% for the fourth quarter of 2020, compared to operating margin of 9.5% for the same period of last year.

Net Income (Loss)

Net loss was $2.7 million, or $0.06 loss per basic and diluted share, for the fourth quarter of 2020, compared to net income of $2.2 million, or $0.10 per basic and diluted share, for the same period of last year.

EBITDA

EBITDA was $1.6 million for the fourth quarter of 2020, compared to $7.0 million for the same period of last year.

Note 1: Non-GAAP Financial Measures

In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission ("SEC"). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company's presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.

Reconciliation of Net Income to EBITDA

(Amounts expressed in US$)









 For the Three Months Ended December 31,

 ($ millions)


2020



2019

 Net income (loss)


-2.69



2.16

 Add: Income tax


-0.52



0.87

         Net interest expense


0.28



0.20

         Depreciation and amortization


4.49



3.76

 EBITDA


1.56



6.98

 

Full Year Ended December 31, 2020 Financial Results



 For the Twelve Months Ended December 31,

 ($ millions)


2020


2019


 % Change

 Revenues


100.94


117.61


-14.2%

 Regular Corrugating Medium Paper ("CMP")*


62.32


72.05


-13.5%

 Light-Weight CMP**


16.84


18.78


-10.3%

 Offset Printing Paper


12.27


20.44


-40.0%

 Tissue Paper Products


8.41


6.35


32.5%

  Face Masks


1.10


NM


NM








 Gross profit


5.70


13.68


-58.3%

 Gross profit (loss) margin


5.6%


11.6%


-6.0 pp****

 Regular Corrugating Medium Paper ("CMP")*


5.4%


10.3%


-4.9 pp****

 Light-Weight CMP**


8.9%


10.1%


-1.2 pp****

 Offset Printing Paper


17.3%


31.2%


-13.9 pp****

 Tissue Paper Products***


-21.7%


-31.5%


9.7 pp****

 Face Masks


48.1%


NM


NM








 Operating income (loss)


-5.46


3.90


-240.0%

 Net income


-5.55


2.22


-350.0%

 EBITDA


10.16


19.33


-47.4%

 Basic and Diluted earnings (loss) per share


-0.21


0.10


-307.9%








 * Products from PM6







 ** Products from PM1







 *** Products from PM8 and PM9







 **** pp represents percentage points







 

Revenue

For the year ended December 31, 2020, total revenue decreased by $16.7 million, or 14.2%, to $100.9 million from $117.6 million for 2019. The decrease in total revenue was mainly due to a decrease in sales volume of Regular CMP, offset printing paper and a decrease in ASPs over all paper products categories. The following table summarizes revenue, volume and ASP by product for the years ended December 31, 2020 and 2019, respectively:


 For the Twelve Months Ended December 31,


2020


2019


 Revenue ($'000)


 Volume (tonne)


 ASP ($/tonne)


 Revenue ($'000)


 Volume (tonne)


 ASP ($/tonne)

 Regular CMP

62,325


154,084


404


72,050


168,837


427

 Light-Weight CMP

16,836


42,801


393


18,776


45,310


414

 Offset Printing Paper

12,266


20,358


603


20,436


29,207


700

 Tissue Paper Products

8,415


10,088


834


6,351


6,790


935

 Total

99,841


227,331


439


117,614


250,144


470


 Revenue ($'000)


 Volume (thousand pieces)


 ASP ($/thousand pieces)


 Revenue ($'000)


 Volume ($/thousand pieces)


 ASP ($/thousand pieces)

 Face Masks

1,102


10,301


107


 NM


 NM


 NM

Revenue from CMP, including both regular CMP and light-Weight CMP decreased by $11.7 million, or 12.8%, to $79.2 million, and accounted for 78.4% of total revenue for the year ended December 31, 2020, compared to $90.8 million, or 77.2% of total revenue for 2019. The Company sold 196,885 tonnes of CMP at an ASP of $402/tonne in the year ended December 31, 2020, compared to 214,147 tonnes at an ASP of $424/tonne in 2019.

Of the total CMP sales, revenue from regular CMP decreased by $9.7 million, or 13.5%, to $62.3 million, resulting from sales of 154,084 tonnes at an ASP of $404/tonne during the year ended December 31, 2020, compared to revenue of $72.1 million, resulting from sales of 168,837 tonnes at an ASP of $427/tonne for 2019. Revenue from light-weight CMP decreased by $1.9 million, or 10.3%, to $16.8 million, resulting from sales of 42,801 tonnes at an ASP of $393/tonne for the year ended December 31, 2020, compared to revenue of $18.8 million, resulting from sales of 45,310 tonnes at an ASP of $414/tonne for 2019.

Revenue from offset printing paper decreased by $8.1 million, or 40.0%, to $12.3 million for the year ended December 31, 2020 from $20.4 million for 2019. The Company sold 20,358 tonnes of offset printing paper at an ASP of $603/tonne in the year ended December 31, 2020, compared to 29,207 tonnes at an ASP of $700/tonne in 2019.

Revenue from tissue paper products increased by $2.1 million, or 32.5%, to $8.4 million, resulting from sales of 10,088 tonnes at an ASP of $834/tonne, for the year ended December 31, 2020, compared to revenue of $6.4 million, resulting from sales of 6,790 tonnes at an ASP of $935/tonne for 2019.

Revenue generated from selling face masks was $1.1 million for the year ended December 31, 2020. The Company sold 10,301 thousand pieces of face masks for the year ended December 31, 2020.

Gross Profit and Gross Margin

Total cost of sales decreased by 8.7 million, or 8.4%, to $95.2 million for the year ended December 31, 2020 from $104.0 million for 2019. The decrease in overall cost of sales was mainly due to the decreased sales volume of CMP and offset printing paper in the year ended December 31, 2020.  Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper, tissue paper products were, $383, $358, $498, and $1,015, respectively, for the year ended December 31, 2020 compared to $383, $372, $481, and $1,230, respectively, for 2019.

Total gross profit decreased by $8.0 million, or 58.3%, to $5.7 million for the year ended December 31, 2020 from $13.7 million for 2019. Overall gross margin decreased by 6.0 percentage points to 5.6% for the year ended December 31, 2020 from 11.6% for 2019. Gross margins for regular CMP, light-weight CMP, offset printing paper, tissue paper products and face mask products were 5.4%, 8.9%, 17.3%, -21.7% and 48.1%, respectively, for the year ended December 31, 2020, compared to 10.3%, 10.1%, 31.2%, -31.5% and nil, respectively, for 2019.

Selling, General and Administrative Expenses

SG&A expenses increased by $1.4 million, or 14.1%, to $11.2 million for the year ended December 31, 2020 from $9.8 million for 2019. As a percentage of total revenue, SG&A expenses was 11.1% for the year ended December 31, 2020, compared to 8.3% for 2019.

Income (Loss) from Operations

Loss from operations increased by $9.4 million, or 240.0%, to $5.5 million for the year ended December 31, 2020 from income from operations of $3.9 million for 2019. Operating loss margin was 5.4% for the year ended December 31, 2020, compared to operating margin of 3.3% for 2019.

Net Income (Loss)

Net loss increased by $7.8 million, or 350.0%, to $5.6 million, or loss per basic and diluted share of $0.21, for the year ended December 31, 2020, compared to net income of $2.2 million, or earnings per basic and diluted share of $0.10, for 2019.

EBITDA

EBITDA decreased by $9.1 million, or 47.4%, to $10.2 million for the year ended December 31, 2020 from $19.3 million for 2019.

Note 1: Non-GAAP Financial Measures

In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission ("SEC"). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company's presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.

Reconciliation of Net Income to EBITDA

(Amounts expressed in US$)



 For the Twelve Months Ended December 31,

 ($ millions)


2020



2019

 Net income (loss)


-5.55



2.22

 Add: Income tax


-1.10



1.08

         Net interest expense


1.03



0.73

         Depreciation and amortization


15.79



15.30

 EBITDA


10.16



19.33

Cash, Liquidity and Financial Position

As of December 31, 2020, the Company had cash and bank balances, short-term debt (including bank loans, current portion of long-term loans from credit union and related party loans), and long-term debt (including loan from credit union) of $4.14 million, $12.16 million and $4.60 million, respectively, compared to $5.84 million, $8.31 million and $7.37 million, respectively, at the end of 2019.

Net accounts receivable was $2.39 million as of December 31, 2020, compared to $3.12 million as of December 31, 2019. Net inventory was $1.23 million as of December 31, 2020, compared to $1.61 million at the end of 2019. As of December 31, 2020, the Company had current assets of $14.91 million and current liabilities of $18.34 million, resulting in a working capital deficit of $3.43 million. This was compared to current assets of $24.04 million and current liabilities of $16.84 million, resulting in a working capital of $7.21 million at the end of 2019.

Net cash provided by operating activities was $16.14 million for the year ended December 31, 2020, compared to net cash provided by operating activities of $7.53 million for 2019. Net cash used in investing activities was $20.53 million for the year ended December 31, 2020, compared to $7.87 million for 2019. Net cash provided by financing activities was $2.05 million for the year ended December 31, 2020, compared to net cash used in financing activities of $5.77 million for 2019.

Recent development

In November 2020, the Company completed inviting bids for the 75 tonne per hour biomass boiler procurement for its biomass cogeneration project. Multiple well-known enterprises in the biomass industry participated in tendering opening bids. In February 2021, the Company completed evaluation on the bidding proposals and announced that Tai Shan Group Co., Ltd., a top manufacturer in the biomass industry in China, has won the bid. Installation of the boilers is expected to commence in the near future. The Company expects to participate in the bidding process for urban central heating projects.

On January 12, 2021, the Company announced it has submitted its application for the license for its new single-use surgical masks from local food and drug administration in Hebei province. Production of its single-use non-medical face masks was in full capacity as the number of confirmed Covid-19 cases surged again and anti-Covid-19 efforts became increasingly normalized globally. 

On January 20, 2021, the Company offered and sold to certain institutional investors an aggregate of 26,181,818 shares of common stock and 26,181,818 warrants to purchase up to 26,181,818 shares of common stock in a best-efforts public offering for gross proceeds of approximately $14.4 million. The purchase price for each share of common stock and the corresponding warrant sold in the offering was $0.55. The warrants are exercisable commencing on January 20, 2021 at an exercise price of $0.55 and will expire on January 20, 2026. The Company intends to use the net proceeds from the offering for general corporate and working capital purposes.

On March 1, 2021, the Company offered and sold to the public investors an aggregate of 29,277,866 shares of common stock and 14,638,933 warrants to purchase up to 14,638,933 shares of common stock in a firm commitment underwritten public offering for gross proceeds of approximately $21.9 million. The purchase price for each share of common stock and accompanying warrant sold in the offering was $0.75. The warrants are exercisable commencing on March 1, 2021 at an exercise price of $0.75 and will expire on March 1, 2026. The Company intends to use the net proceeds from the offering for general corporate and working capital purposes.

Earnings Conference Call

The Company's management will host a conference call to discuss its fourth quarter and fiscal year 2020 financial results at 8:00 am US Eastern Time on Wednesday, March 24, 2021. To attend the conference call, please use the information below.

Conference Topic: IT Tech Packaging Inc. Fourth Quarter and Fiscal Year 2020 Earnings Conference Call and Webcast

Date of call: March 24, 2021

Time of call: 8:00 AM Eastern Time (8:00 PM Beijing/Hong Kong Time)

Conference ID: 8679484

To attend the conference call, please register in advance of the conference using the link: http://apac.directeventreg.com/registration/event/8679484 to complete the online registration at least 15 minutes prior to the start of the call. Upon registering, the conference access information including participant dial-in numbers, a Direct Event passcode and a registrant ID will be provided to you via an email.

This conference call will be broadcast live on the Internet and can be accessed by all interested parties at https://edge.media-server.com/mmc/p/5soq5wdd. Please access the link at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software.

A playback will be available through 11:00 am ET on March 24, 2021 to 8:59 am ET on April 1, 2021. To listen, please dial+1-855-452-5696 if calling fromthe United States, or +61-281-990-299 if calling internationally. Use the conference ID 8679484 to access the replay.

About IT Tech Packaging, Inc.

Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China's Hebei Province, ITP is located strategically close to the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For more information, please visit: http://www.itpackaging.cn/ .

Safe Harbor Statements

This press release may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company's public filings with the Securities and Exchange Commission, including the Company's latest annual report on Form 10-K. All information provided in this press release speaks as of the date hereof. Except as otherwise required by law, the Company undertakes no obligation to update or revise its forward-looking statements.

For more information, please contact:

At the Company
Email: ir@itpackaging.cn 
Tel: +86 0312 8698215

Investor Relations:
Janice Wang
EverGreen Consulting Inc.
Email: ir@changqingconsulting.com
Phone: +1 571-464-9470 (from U.S.)  
+86 13811768559 (from China)

 

IT TECH PACKAGING, INC. 

CONSOLIDATED BALANCE SHEETS 

AS OF DECEMBER 31, 2020 AND 2019




December 31,



December 31,




2020



2019


ASSETS














Current Assets







Cash and bank balances


$

4,142,437



$

5,837,745


Restricted cash



-




-


Accounts receivable (net of allowance for doubtful accounts of $34,391 and $59,922 as

of December 31, 2020 and December 2019, respectively)



2,389,057




3,119,311


Inventories



1,233,801




1,607,463


Prepayments and other current assets



7,051,515




11,613,241


Due from related parties



92,795




1,863,479


Total current assets



14,909,605




24,041,239











Prepayment on property, plant and equipment



21,149,749




1,433,445


Finance lease right-of-use assets, net



2,397,653




-


Property, plant, and equipment, net



145,142,642




151,616,852


Value-added tax recoverable



2,566,195




2,621,841


Deferred tax asset non-current



13,708,630




10,485,053











Total Assets


$

$199,874,474



$

190,198,430











LIABILITIES AND STOCKHOLDERS' EQUITY


















Current Liabilities









Short-term bank loans


$

6,435,348



$

6,163,814


Current portion of long-term loans from credit union



4,996,245




1,605,459


Lease liability



182,852




-


Accounts payable



592,391




250,486


Advance from customers



82,625




98,311


Due to related parties



727,433




539,985


Accrued payroll and employee benefits



224,930




291,924


Other payables and accrued liabilities



4,838,601




6,503,010


Income taxes payable



259,649




1,382,471











Total current liabilities



18,340,074




16,835,460











Loans from credit union



4,597,772




7,367,908


Deferred gain on sale-leaseback



387,087




-


Lease liability - non-current



354,107




-


Derivative liability



1,115,260




-











Total liabilities (including amounts of the consolidated VIE without recourse to the Company of $17,950,224 and $19,558,568 as of December 31, 2020 and 2019, respectively)



24,794,300




24,203,368











Commitments and Contingencies


















Stockholders' Equity









Common stock, 500,000,000 shares authorized, $0.001 par value per share, 28,535,816 and 22,054,816 shares issued and outstanding as of December 31, 2020 and December, 31,2019, respectively



28,536




22,055


Additional paid-in capital



53,989,548




51,155,174


Statutory earnings reserve



6,080,574




6,080,574


Accumulated other comprehensive income (loss)



5,740,722




(6,057,537)


Retained earnings



109,240,794




114,794,796











Total stockholders' equity



175,080,174




165,995,062











Total Liabilities and Stockholders' Equity


$

199,874,474



$

190,198,430


 

IT TECH PACKAGING, INC. 

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) 

FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019




Year Ended




December 31,




2020



2019









Revenues


$

100,943,269



$

117,614,886











Cost of sales



(95,241,284)




(103,935,368)











Gross Profit



5,701,985




13,679,518











Selling, general and administrative expenses



(11,157,789)




(9,781,719)


Gain on acquisition of a subsidiary



-




-











(Loss) Income from Operations



(5,455,804)




3,897,799











Other Income (Expense):









Interest income



32,033




64,717


Subsidy income



220,478




261,136


Interest expense



(1,026,512)




(926,368)


Loss on derivative liability



(426,055)




-











(Loss) Income before Income Taxes



(6,655,860)




3,297,284











Provision for Income Taxes



1,101,858




(1,076,102)











Net (Loss) Income



(5,554,002)




2,221,182











Other Comprehensive Income (Loss)









Foreign currency translation adjustment



11,798,259




(2,793,585)











Total Comprehensive Income (Loss)


$

6,244,257



$

(572,403)











(Losses) Earnings Per Share:


















Basic and Diluted (Losses) Earnings per Share


$

(0.21)



$

0.10











Outstanding – Basic and Diluted



26,498,298




22,034,905


 

IT TECH PACACKING, INC. 

CONSOLIDATED STATEMENTS OF CASH FLOWS 

FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019




Year Ended




December 31,




2020



2019


Cash Flows from Operating Activities:







Net income


$

(5,554,002)



$

2,221,182


Adjustments to reconcile net income to net cash provided by operating activities:









Depreciation and amortization



15,793,854




15,304,039


Loss on derivative liability



426,055




-


Allowances for obsolete inventories, net



-




75,719


(Recovery from) Allowance for bad debts



(28,087)




2,192


Share-based compensation and expenses



1,256,700




-


Gain on acquisition of a subsidiary



-




-


Deferred tax



(2,364,575)




(2,369,683)


Changes in operating assets and liabilities:









Accounts receivable



923,429




(294,882)


Prepayments and other current assets



5,301,953




(5,392,916)


Inventories



458,878




1,207,958


Accounts payable



307,198




(372,728)


Advance from customers



(21,281)




99,472


Notes payable



-




(3,625,921)


Related parties



1,984,619




(1,757,231)


Accrued payroll and employee benefits



(82,516)




82,813


Other payables and accrued liabilities



(1,105,508)




1,169,967


Income taxes payable



(1,153,191)




1,180,493


Net Cash Provided by Operating Activities



16,143,526




7,530,474











Cash Flows from Investing Activities:









Purchases of property, plant and equipment



(21,106,210)




(6,416,481)


Proceeds from sale of property, plant and equipment



580,206






Acquisition of a subsidiary



-




(1,450,368)


Net Cash Used in Investing Activities



(20,526,004)




(7,866,849)











Cash Flows from Financing Activities:









Proceeds from issuance of shares and warrants, net



2,273,360




-


Repayments of related party loans



-




(2,175,553)


Proceeds from short term bank loans



6,090,715




10,152,579


Proceeds from credit union loans



-




4,206,068


Repayment of bank loans



(6,237,217)




(17,955,561)


Payment of capital lease obligation



(72,003)




-











Net Cash Provided by (Used in) Financing Activities



2,054,855




(5,772,467)











Effect of Exchange Rate Changes on Cash and Cash Equivalents



632,315




(170,838)











Net (Decrease) Increase in Cash and Cash Equivalents



(1,695,308)




(6,279,680)











Cash, Cash Equivalents and Restricted Cash - Beginning of Year



5,837,745




12,117,425











Cash, Cash Equivalents and Restricted Cash - End of Year


$

4,142,437



$

5,837,745











Supplemental Disclosure of Cash Flow Information:









Cash paid for interest, net of capitalized interest cost


$

592,140



$

926,368


Cash paid for income taxes


$

2,401,191



$

2,250,546











Cash and bank balances



4,142,437




5,837,745


Restricted cash



-




-


Total cash, cash equivalents and restricted cash shown in the statement of cash flows



4,142,437




5,837,745


 

Cision View original content:http://www.prnewswire.com/news-releases/it-tech-packaging-inc-announces-fourth-quarter-and-fiscal-year-2020-financial-results-301254333.html

SOURCE IT Tech Packaging, Inc.

FAQ

What were IT Tech Packaging's Q4 2020 revenue and net loss?

In Q4 2020, IT Tech Packaging reported revenues of $32.48 million and a net loss of $2.69 million.

How did IT Tech Packaging perform in the full year 2020?

For the full year 2020, IT Tech Packaging's revenues decreased by 14.2% to $100.94 million, with a net loss of $5.55 million.

What factors contributed to the revenue decline for IT Tech Packaging in 2020?

The revenue decline was mainly due to decreased sales volumes of Regular and Offset Printing paper products.

What growth did IT Tech Packaging experience in tissue paper products?

Tissue paper product sales increased by 51.3% in Q4 2020.

IT Tech Packaging, Inc.

NYSE:ITP

ITP Rankings

ITP Latest News

ITP Stock Data

2.57M
10.07M
5.38%
3.67%
Paper & Paper Products
Converted Paper & Paperboard Prods (no Contaners/boxes)
Link
United States of America
HEBEI PROVINCE,